Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Poor Prognosis With Different Induction Rate Was Observed In Children With Acute Myeloid Leukemia and FLT3 -ITD According To The ITD/WT Allelic Ratio: A Result From The Japanese Pediatric Leukemia/Lymphoma Study Group

Blood (2013) 122 (21): 3891.

https://doi.org/10.1182/blood.V122.21.3891.3891

Published: 2013

Journal Articles

Rapid Reduction of Chronic Myeloid Leukemia Stem Cells After Treatment with Second-Generation BCR-ABL Kinase Inhibitors, Dasatinib and Nilotinib

Yosuke Minami, MD, PhD, Akihiro Abe, Yuka Nomura, Miho Minami, Yachiyo Kuwatsuka, Kunio Kitamura, Junji Hiraga, Shinichi Mizuno, Kazuhito Yamamoto, Tomohiro Kajiguchi, Masashi Sawa, Yuichiro Inagaki, Toshiya Yokozawa, Etsuko Aoki, Kazutaka Ozeki, Keisuke Watanabe, Koichi Miyamura, Hitoshi Kiyoi, Tomoki Naoe

Blood (2010) 116 (21): 4457.

https://doi.org/10.1182/blood.V116.21.4457.4457

Published: 2010

Journal Articles

Serum α1-Acid Glycoprotein Level Associate with Imatinib Trough Plasma Concentration and Clinical Outcome in CML Patients Treated with Imatinib: Blood Level Testing of Imatinib in Nagoya (BINGO) Study.

Yuichi Ishikawa, MD, PhD, Hitoshi Kiyoi, MD, PhD, Keisuke Watanabe, MD, Yasuyuki Nakano, MD, PhD, Kunio Kitamura, MD, PhD, Akio Kohno, MD, PhD, Toshiya Yokozawa, MD, PhD, Isamu Sugiura, MD, PhD, Akitoshi Hanamura, MD, PhD, Hiroatsu Iida, MD, PhD, Kazuhito Yamamoto, MD, PhD, Ritsuro Suzuki, MD, PhD, Koichi Miyamura, MD, PhD, Nobuhiko Emi, MD, PhD, Kazunori Ohnishi, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2009) 114 (22): 4266.

https://doi.org/10.1182/blood.V114.22.4266.4266

Published: 2009

Journal Articles

Clinical Characteristics and Outcomes in Patients with t(8;21) Acute Myeloid Leukemia in Japan.

Hiroto Narimatsu, MD, Toshiya Yokozawa, MD, Hiroatsu Iida, MD, Motohiro Tsuzuki, MD, Masaya Hayakawa, MD, Takaaki Takeo, MD, Masaki Iino, MD, Takuji Ichihashi, MD, Chiaki Kato, MD, Akiyo Sawamoto, MD, Hiroshi Sao, MD, Masamitsu Yanada, MD, Nobuhiko Emi, MD, Hitoshi Kiyoi, MD, Tetsushi Yamaguchi, MD, Tomoki Naoe, MD, Ritsuro Suzuki, MD, Isamu Sugiura, MD

Blood (2007) 110 (11): 4269.

https://doi.org/10.1182/blood.V110.11.4269.4269

Published: 2007

Journal Articles

Detection of p57KIP2 Gene Methylation Is Useful Marker for Minimal Residual Disease in Diffuse Large B Cell Lymphoma.

Kazumi Hagiwara, Hirokazu Nagai, M.D., Toshiya Yokozawa, M.D., CHiaki Kato, M.D., Motohiro Hamaguchi, M.D., Tomomitsu Hotta, M.D., Keizo Horibe, M.D.

Blood (2007) 110 (11): 4415.

https://doi.org/10.1182/blood.V110.11.4415.4415

Published: 2007

Journal Articles

Early Intervention in Minimal Residual Disease after Allogeneic Transplant for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Prolonged Survival by Imatinib.

Koichi Miyamura, Kodera Yoshihisa, Satoshi Skamaki, Shinji Nakao, Satoshi Sasaki, Toshiya Yokozawa, Chiaki Kato

Blood (2005) 106 (11): 4581.

https://doi.org/10.1182/blood.V106.11.4581.4581

Published: 2005

Journal Articles

Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12)

Yoshie Kuno, Akihiro Abe, Nobuhiko Emi, Minako Iida, Toshiya Yokozawa, Masayuki Towatari, Mitsune Tanimoto, Hidehiko Saito

Blood (2001) 97 (4): 1050–1055.

https://doi.org/10.1182/blood.V97.4.1050

Published: 2001

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Poor Prognosis With Different Induction Rate Was Observed In Children With Acute Myeloid Leukemia and FLT3 -ITD According To The ITD/WT Allelic Ratio: A Result From The Japanese Pediatric Leukemia/Lymphoma Study Group

Rapid Reduction of Chronic Myeloid Leukemia Stem Cells After Treatment with Second-Generation BCR-ABL Kinase Inhibitors, Dasatinib and Nilotinib

Serum α1-Acid Glycoprotein Level Associate with Imatinib Trough Plasma Concentration and Clinical Outcome in CML Patients Treated with Imatinib: Blood Level Testing of Imatinib in Nagoya (BINGO) Study.

Clinical Characteristics and Outcomes in Patients with t(8;21) Acute Myeloid Leukemia in Japan.

Detection of p57KIP2 Gene Methylation Is Useful Marker for Minimal Residual Disease in Diffuse Large B Cell Lymphoma.

Early Intervention in Minimal Residual Disease after Allogeneic Transplant for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Prolonged Survival by Imatinib.

Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12)

Email alerts

ASH Publications

American Society of Hematology

Update search

Poor Prognosis With Different Induction Rate Was Observed In Children With Acute Myeloid Leukemia and FLT3 -ITD According To The ITD/WT Allelic Ratio: A Result From The Japanese Pediatric Leukemia/Lymphoma Study Group

Rapid Reduction of Chronic Myeloid Leukemia Stem Cells After Treatment with Second-Generation BCR-ABL Kinase Inhibitors, Dasatinib and Nilotinib

Serum α1-Acid Glycoprotein Level Associate with Imatinib Trough Plasma Concentration and Clinical Outcome in CML Patients Treated with Imatinib: Blood Level Testing of Imatinib in Nagoya (BINGO) Study.

Clinical Characteristics and Outcomes in Patients with t(8;21) Acute Myeloid Leukemia in Japan.

Detection of p57KIP2 Gene Methylation Is Useful Marker for Minimal Residual Disease in Diffuse Large B Cell Lymphoma.

Early Intervention in Minimal Residual Disease after Allogeneic Transplant for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Prolonged Survival by Imatinib.

Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only